We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

9045:TSEKeihan Holdings Co.,Ltd. Analysis

Data as of 2026-06-14 - not real-time

¥3,195.00

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Keihan Holdings posted a 34.2% revenue jump to ¥332.5 bn and maintained a healthy net profit margin of 10.1%, yet its free cash flow turned negative at ¥‑11.5 bn and debt‑to‑equity sits at a high 112%. The stock trades at a PE of 11.4, well below the industry average of 30.6, and its PB of 0.94 suggests a discount to book value, while the dividend yield of 2.69% with a modest 14.3% payout ratio appears sustainable. Technically, the price of ¥3,195 is just above the 20‑day SMA (¥3,179) but remains under the 50‑day (¥3,244) and 200‑day (¥3,323) averages, the RSI sits at 48.2, and a bullish MACD histogram (+7.86) hints at short‑term momentum despite overall bearish trend and decreasing volume. The DCF model estimates a fair value near ¥6,401, implying an upside of roughly 8.8% over the current level, though the high leverage and negative free cash flow temper enthusiasm.
Given a very low beta of 0.15, the stock exhibits limited market‑wide volatility, but a 30‑day volatility of 26.6% and a max drawdown of –14.9% signal notable price swings. Sector risk is moderate for a Japanese conglomerate, while regulatory, geographic, and currency risks are low; liquidity risk is medium due to the falling volume trend. The extreme greed reading (89.9) reflects strong market appetite, but investors should weigh the upside against debt concerns. Overall, the stock appears modestly undervalued with a sustainable dividend, making a cautious hold stance prudent in the short run and a more optimistic outlook over medium to long horizons.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price marginally above 20‑day SMA but below longer SMAs
  • Bullish MACD histogram amid decreasing volume
  • Neutral RSI around 48

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Significant revenue growth (34% YoY) and solid profit margins
  • Low PE relative to industry and attractive dividend yield
  • DCF upside of ~8.8% indicating valuation room

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Sustainable dividend supported by low payout ratio
  • Strong ROE (~10%) and stable operating margins
  • Potential deleveraging and cash‑flow improvement over time

Key Metrics & Analysis

Financial Health

Revenue Growth34.20%
Profit Margin10.10%
P/E Ratio11.4
ROE10.46%
ROA3.47%
Debt/Equity112.33
P/B Ratio0.9
Op. Cash Flow¥40.3B
Free Cash Flow¥-11521375232
Industry P/E30.6

Technical Analysis

TrendBearish
RSI48.2
Support¥3,029.00
Resistance¥3,277.00
MA 20¥3,178.90
MA 50¥3,243.74
MA 200¥3,323.11
MACDBullish
VolumeDecreasing
Fear & Greed Index89.86

Valuation

Fair Value¥6,400.71
Target Price¥3,475.00
Upside/Downside8.76%
GradeUndervalued
TypeBlend
Dividend Yield2.69%

Risk Assessment

Beta0.15
Volatility26.64%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.